Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen -- Ignore unavailable to you. Want to Upgrade?

To: tom pope who wrote (3806)	1/23/2001 3:33:53 PM
From: RJMC	Read Replies (1) \| Respond to of 5665

Hey! Looks like some newsworthy items are finally approaching. Nice to see that Mr. Lambert is out there doing a road show. Who knows, may even be some additional partnerships in the offing. Nice news on Amgen yesterday. IMGN certainly wants as much breadth as possible on its intellectual property and rulings like the one for Amgen certainly help. The more IMGN can lock-up its TAP technology, the better off the company is. Still don't see any real competition out there with IMGN. Seems to be a lot of protein based prodrugs that are akin to the old Oncolysin but I haven't seen anyone who is looking at the small molecule arena like Immunogen is. Looks like the market is finally starting to warm-up to the biotech sector again. The last few weeks were a little rough but the BTK index looks like it is starting to pick-up some steam! Bob M.